John Hammergren over the course of his 13-year tenure as sole CEO of San Francisco-based McKesson Corp. helped triple sales and transformed the sprawling $123 billion supply-chain behemoth into the 14th-largest corporation in America.
In the process, he also turned himself into a poster child for stockholder activists challenging out-of-control CEO pay, and his company became a target of federal and state prosecutors.
Last summer, Hammergren, 55, faced off with shareholders critical of his $159 million pension plan. In addition he earned an overall $51.7 million compensation package in 2013, a 30% bump from the $39.7 million he received in 2012. That put him atop Modern Healthcare's list of top-paid healthcare officials in 2013.
The huge payout, scaled back in February of this year after the stockholder protests, came a year after the company settled allegations it had overcharged for prescription drugs. McKesson paid at least $900 million in legal costs, including a $483 million settlement in fiscal 2013, to resolve the allegations.